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Prolonged Rat Cardiac Preservation with UW Lactobionate Solution 
Leonard Makowka, Tony R. Zerbe,l Frances Chapman, Shiguang Qian, 
Hong Sun, Noriko Murase, Robert Kormos, James Snyder, and Thomas E. Starzl 
T HE MOST significant limiting factor in the further 
expansion of clinical cardiac transplantation consists of 
the availability of suitable donors and the duration of viabil-
ity of the organ following harvest. Currently, the safe limits 
of static cold cardiac preservation are considered to be four to 
six hours using the standard Stanford preservation solution 
as listed in Table 1. Belzer and colleagues have developed a 
preservation solution known as the University of Wisconsin 
(UW) lactobionate cold-storage solution (Table 1) which has 
demonstrated consistent 72 hour and 30 hour or longer 
preservation of the pancreas and liver, respectively. I 
Prompted by these successes and significant advances in 
static cold preservation, we compared UW-solution and the 
traditional Stanford solution for cardiac preservation in a 
heterotopic heart transplant model in rats. Additional phar-
macologic manipulation with an antagonist of Platelet-
Activating Factor (PAF), which has been shown to amelio-
rate ischemic liver injury/ and with an oxygen free radical 
scavenger (SOD) were evaluated. 
MATERIALS AND METHODS 
Animals 
Inbred male Lewis (RTI') rats (220-250 grams) were purchased 
from Harlan Sprague Dawley, Indianapolis, Indiana. Syngeneic 
heterotopic heart transplants were performed in all studies and 
animals were randomly assigned to the study groups. 
Rats were acclimatized in a central animal facility for at least two 
weeks prior to investigation and received standard rat chow and 
water ad libitum. 
Surgical Procedures 
Rats were anesthetized with 40 mg/kg sodium pentobarbital (IPl 
and maintained with inhalational methoxyflurane. 
Donor 
Organs were prepared by entering the chest cavity, clamping the 
inferior vena cava, venting the heart and perfusing through the 
aortic arch with 2 cc of heparinized (200 u/ml) group specific 
preservation solution. The inferior and superior vena cavae were 
ligated and divided. and the other major vessels were divided 
simultaneously. A ligature was secured around the heart and the 
organ was then removed and placed in cold (4°C) group specific 
preservation medium for 12 or 18 hours of cold ischemic preservation 
time (CIT). 
Recipient 
The technique for surgical implantation of the primarily vascular-
ized heterotopic cardiac transplant in rats has been described 
previously.) Briefly, an end-to-side anastomosis is performed 
between the donor and recipient aorta, as well as the donor pulmo-
nary artery to recipient vena cava. 
Graft Evaluation 
Impulses of the transplanted hearts were monitored daily by palpa-
tion through the abdominal wall for a period of 3 days or until hearts 
ceased to function. The intensity of the cardiac impulse was graded 
on a scale of 0-4 (4 being a maximal impulse). 
Experimental Groups 
Animals were randomly divided into: Group I: UW -12 hours CIT; 
Group 2: UW plus SRI 63-441-12 hour CIT; Group 3: UW plus 
SRI 63-441 plus SOD-I 2 hour CIT; Group 4: lJW-18 hour CIT; 
Group 5: Stanford-12 hour CIT; Group 6: Stanford-18 hour 
CIT. 
Pharmacologic Administration 
SRI 63-441: The specific receptor antagonist of PAF, SRI 63-441, 
was supplied by Sandoz Research Institute (East Hanover, New 
Jersey) and its properties and pharmacology have been described 
elsewhere.' The powdered form (MW 662) was reconstituted in 
0.68% sodium acetate buffer and 0.9% sodium chloride (pH 5.3) to a 
final concentration of 10 mg/ml, and placed in a warm water bath 
(26-28°C) for a period of 5 minutes. A single bolus injection of 20 
mg/ml was administered to the donor via the inferior vena cava 4 
minutes prior to harvest. 
Superoxide Dismutase (SOD). Human recombinant SOD was sup-
plied by Pharmacia AB. Uppsala, Sweden. It was diluted in 0.9% 
sodium chloride to a final concentration of 8 mg!ml and adminis-
tered intravenously to the recipient at a dosage of 15 mg/kg at 2 
minutes prior to revascularization of the heart. 
Pathologic and Biochemical Evaluation 
Biventricular segments of heart were formalin fixed and submitted 
for routine paraffin embedding. Hematoxylin and eosin (H + E) 
slides were prepared and morphological assessment of cardiac injury 
was performed using a semi-quantitati\'e scale of 0 to 4 (4 being most 
severe). Hearts were assigned a score of 5 if they failed to function 
immediately. In functioning cardiac grafts. the myocardium was 
assessed for the following; myocytolysis (dissolution of myocytes), 
myocardial necrosis and inflammatory infiltrate. The degree of 
injury was measured by the extent of myocardium involved in the 
biventricular section, I < 10%,2 <! 10% and", 30%, 3 ~ 30% and < 
60%, 4 ~ 60%. 
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Table 1. Composition of Cold Storage Solutions 
UW·Lactobionate 
Dilute to 1 liter with sterile water 
K·lactobionate· 
Raffinose 
KH.PO. 
Mg SO. 
Adenosine 
Glutathione 
Insulin 
Bactrim 
Dexamethasone 
Allopurinol 
Hydroxethyl starch solution· 
100 mmol 
30 mmol 
25 mmol 
5mmol 
5mmol 
3mmol 
100 U 
0.5 ml 
8mg 
1 mmol 
50 grams 
·A generous gift from American Critical Care, McGraw Park, IL. 
Measurements of A TP levels were performed for the 12-hour CIT 
group at 3 and 7 hours following revascularization of the heart and at 
postoperative day 3. At sacrifice. the heart was excised and rapidly 
frozen with a Wallen berger clamp precooled in liquid nitrogen. The 
frozen sample was used to determine the concentration of ATP 
according to the methodology described by Lamprecht and Traut-
sehold.1 The animal's own heart served as a control. 
Statistics 
Graft survival times and A TP levels for each of the experimental 
groups were expressed as a mean and standard error of the mean and 
were compared using Student's t·lest. For histologic analysis. the 
group ischemic scores were tested for differences in distribution 
using a non parametric rank sum. A p value of <0.05 was considered 
statistically significant. 
RESULTS 
Cardiac survival after 12 and 18 hours of CIT is summarized 
in Table 2 
Twelve Hour Preservation 
Grossly, upon revascularization of the transplanted organ, all 
hearts including those UW-grafts treated with either SRI 
63-441 alone or in combination with SOD, developed an 
immediate and effective impulse. No difference was noted 
between any of the groups for the interval between revascu-
larization and the initial contraction. In all but one case 
(Group 5), hearts maintained a 3-4 + impulse until sacrifice 
at postoperative day 3. While these grafts continued to 
Standard 
To 1 liter of 5% Dextrose 
Mannitol 
Sodium bicarbonate 
KCL 
12.5 grams 
25MEO 
20MEO 
function as determined by palpation, abnormalities such as 
edema, hemorrhagic areas and paleness in color of the grafts 
were evident at the time of revascularization, and were more 
pronounced in the hearts stored in the Stanford solution. 
18 Hour Preservation 
Hearts preserved in the Stanford solution, for the most part, 
failed to function immediately. One graft survived with a 
slight impUlse for 5 hours, while all others became severely 
edematous and hemorrhagic immediately following revascu-
larization. Conversely, 66'7c of the cardiac grafts stored in 
UW survived until the time of sacrifice at postoperative day 
3. Generally, the interval between revascularization and 
initial impulse was prolonged in hearts preserved in UW-
lactobionate and all hearts failed to achieve a 4+ impulse. 
It is evident from the graft survival data in Table 2, that 
between 12 and 18 hours of preser.ation there is a significant 
influence of the LW solution on graft viability in the 
heterotopic position. Administration of SRI 63-441 either 
alone or in combination with SOD did not further augment 
the effect of the UW solution on cardiac preservation either 
in terms of graft survival (Table 2) or as exhibited by the 
degree of morphologic injury present (Fig I). 
The ability of UW to maintain myocardial energy levels is 
also apparent for the 12 hour CIT group as evidenced by the 
A TP levels measured at 3 hours postoperatively (LJW: 1.89 :t 
0.24 versus S: 0.62 :t 0.16. p < 0.001). Values for the UW 
and Stanford grafts at three days were not statistically 
different as compared to native hearts. 
Table 2_ Cardiac Survival after CIT 
Group 
1 
2 
3 
4 
5 
6 
Solution 
uw 
UW + SRI 63·441 
UW + SRI 63·441 + SOD 
UW 
Stanford 
Stanford 
'p < 0.001 for UW compared to Stanford at 18 hours CIT (t·test). 
N 
14 
7 
7 
8 
13 
8 
Cold Ischemic 
Time 
(hours) 
12 
12 
12 
18 
12 
18 
Gralt 
Survival 
(days) 
3.00 z 0.00 
3.00:!: 0.00 
300:!: 0.00 
2.50 :!: 0.27" 
2.80:!: 0.1 
0.03:!: 0.03 
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Fig 1. The ischemic scores (y axis 0-5) are summarized at 
two time intervals; 12 and lB hours of preservation. At both 
time pOints the ischemia score Is significantly different 
(p < 0.01) when comparing UW solution to the Stanford solu-
tion. No additional improvement was noted in SOD and/or SRI 
63-441 treatment as compared to UW preservation alone. 
All cardiac grafts were evaluated in a blind manner and 
ischemic scores were assessed. The nature of the myocardial 
injury did not appear to be influenced by the preservation 
protocols. The extent of injury was less in the hearts 
preserved in UW -lactobionate solution as shown in Figure I. 
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SOD or SRI 63-441 treatment did not further enhance the 
preserva tion as reflected in the ischemic score received (Fig 
I). 
COMMENTS 
These studies demonstrate a significant difference in the 
degree of cardiac injury after 12 and 18 hours of static cold 
preservation in the UW and Stanford solutions as deter-
mined by cardiac survival, ATP levels and histologic evalua-
tion, However, these represent less significant improvements 
when one considers the degree of morphologic myocardial 
injury present at 3 days post transplant. This raises consider-
able doubt as to whether hearts preserved for this time period 
could support the circulation in an orthotopic position. 
Nevertheless, the comparison of the traditional Stanford 
solution to the new UW solution in this model, allows some 
insight into the quality of cardiac preservation that can be 
achieved. The results presented suggest that with further 
modification of the UW preservation solution, extended 
cardiac preservation and viability for transplantation may be 
achieved_ 
REFERENCES 
J. Belzer FD, Southard JH: Transplantation 45(4):673.1988 
2. Ontell SJ, Makowka L, Trager 1, et al: Ann Surg (in press) 
3. Ono K, Lindsey ES: J Thorac Cardiovasc Surg 57(2):225, 
1969 
4. Saunders RN, Handley DA: Ann Rev Pharmacol Toxicol 
27:237,1987 
5. Lamprecht W. Trautschold I: In Bergmeyer HU (ed) Meth-
ods of Enzymatic Analysis. ed 2. New York. AcademIC Press. p 
2101.1974 
